Establishment Labs (ESTA) favored small cap looking to clear multi-week flag and has 1K May $60 calls bought from 10/19 in OI. Establishment Labs Holdings Inc. is a global medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants. Preparations for commercial sales of Mia Femtech are progressing and approval in China is also expected in the first half of 2023. ESTA submitted its modular PMA to the U.S. FDA, bringing it closer to approval of Motiva in the United States. Mizuho raised its target to $95 in January.